DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins 
Anta Sports Expands Global Footprint With Strategic Puma Stake 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions 
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible 
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit 
Amazon Explores AI Content Marketplace With Media Publishers 
TAMPA, Fla., March 15, 2018 -- United Consortium Ltd. (OTC PINK:UCSO), an acquisition and development Company focused on creating shareholder value by identifying and monetizing opportunities in Blockchain, Digital Media and the Emerging Cannabis Space, today announced that its wholly owned subsidiary Block Chain, Inc. has launched the beta version of its new PHR Blockchain project.
UCL Chairman and Chief Executive Officer Scott Gallagher stated, “Today marks an important step forward in our journey to turn our blockchain based idea, into a viable business opportunity with the potential to disrupt how we access and utilize our health records.” Gallagher continued, “We expect the beta period to last several months as we test our methods, collect data and tackle some of the hurdles we’ve identified. Our plan is to have the public version 1.0 set for release this summer. Version 1.0 will have a valuable set of user tools that will transfer complete ownership of personal health records back where it belongs, to the patient.”
About United Consortium Ltd. (UCL)
UCL is an acquisition and development Company focused on creating shareholder value by identifying and monetizing opportunities in Blockchain, Digital Media and the Emerging Cannabis Space. The Company is headquartered in Tampa, Florida. UCL is a current pink sheet Company. The most current information about the Company can be found on OTCMarkets.com or by visiting the Company's website at www.UCLVentures.com.
Forward-Looking Statements
This release contains forward-looking statements that relate to future events or United Consortium Ltd. (UCL's) future performance or financial condition. Any statements that are not statements of historical fact, such as the statements above and including statements containing the words "plans," "anticipates," "expects" and similar expressions, should also be considered to be forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as result of a number of factors, including those described from time to time in United Consortium Ltd.’s filings with the Securities and Exchange Commission, OTC Markets or statement on the Companies websites. United Consortium Ltd. And all of its subsidiary companies undertakes no duty to update any forward-looking statements made herein.
Contact Information
For additional information contact:
Scott Gallagher
727-417-7807
